Welcome to the Tarling and Vallim Labs at UCLA!


We are interested in how cells and tissues adapt to changes in lipids in healthy and diseased states. 

The Tarling Lab is focused on uncovering molecular mechanisms involved in maintaining cholesterol trafficking and homeostasis in immune cells in cardiopulmonary diseases.

The Vallim Lab is interested in identifying novel regulators of lipid metabolism in metabolic disease using a combination of global -omics and gene-targeted approaches.

Follow us on Twitter.

February 2022 – We welcome our new postdoc, Dr. Heidi Schmidt!

September 2022 – Emily passes her oral qualifying exam and is now officially a PhD Candidate!

October 2022 – Kelsey wins 2nd place poster award at the Cardiovascular Theme Symposium. Yay Kesley!

November 2022 – Say hi to Gabriella, who just passsed her oral qualifying exam! Onwards to PhD Candidacy!

Read more

Featured Publications

Take a look at our recent publication, in Cell Metabolism, where we find that activation of the nuclear receptor FXR protects NAFLD through bile-acid dependent reductions in lipid absorption.


Check out our study, published in Nature, where we identify novel lipid biomarkers that predict the accumulation of pathological lipids in the livers of mice and humans.